Skip to main content
logo
COFCO Biotechnology Co., Ltd. (SHE:000930)
China flag China · Delayed Price · Currency is CNY
4.790
-0.030 (-0.62%)
Nov 6, 2026, 3:04 PM CST

COFCO Biotechnology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-130.4138.3725.13-601.631,0591,130
Depreciation & Amortization
511.94511.94506.58491.84458.19449.81
Other Amortization
21.2121.2119.8317.3717.9620.79
Loss (Gain) From Sale of Assets
-60.1-60.10.15-1.16145.82203.22
Asset Writedown & Restructuring Costs
44.1944.192.2754.4513.321.48
Loss (Gain) From Sale of Investments
-33.88-33.88-42.2510.334.08-41.92
Provision & Write-off of Bad Debts
1.611.6135.97-0.150.210.21
Other Operating Activities
-1,080545.07546.17641.07278.15347.89
Change in Accounts Receivable
326.97326.97-199.051,011-1,0522,418
Change in Inventory
433.37433.37-653.64679.8383.07760.34
Change in Accounts Payable
74.7974.79-42.82-287.46-329.12-414.53
Change in Other Net Operating Assets
---4.86-14.35-6.278.67
Operating Cash Flow
53.921,847155.811,958708.444,842
Operating Cash Flow Growth
-95.75%1085.69%-92.04%176.38%-85.37%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-923.29-673.93-483.3-634.52-565.78-1,110
Sale of Property, Plant & Equipment
84.2661.4416.44166.32246.92270.39
Divestitures
-----160.52
Investment in Securities
-102.85--5.6-
Other Investing Activities
-160.0741.8290.22-104.812.6810.96
Investing Cash Flow
-999.1-467.82-376.64-572.99-300.58-667.9

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-6,9696,8777,5656,4378,253
Long-Term Debt Repaid
--7,693-6,115-7,275-6,521-11,627
Lease Payments
-30.04-30.04-31.83-33.76-28.22-23.15
Net Debt Issued (Repaid)
836.15-723.48761.5289.33-84.59-3,374
Common Dividends Paid
-145.58-83.06-93.48-1,172-554.75-277.34
Other Financing Activities
42.2618.95-156.582.9145.05-50.03
Financing Cash Flow
732.83-787.6511.45-880.04-594.28-3,702

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-78.0421.7227.5211.0740.37-4.32
Net Cash Flow
-290.39613.75318.14516.02-146.05467.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-869.381,174-327.491,323142.663,732
Free Cash Flow Growth
---827.69%-96.18%-
Free Cash Flow Margin
-5.23%6.70%-1.63%6.49%0.72%15.84%
Free Cash Flow Per Share
-0.470.63-0.180.720.082.02
Levered Free Cash Flow
-1,3062,437-425.381,267192.13,071
Unlevered Free Cash Flow
-1,2602,490-359.841,337246.553,170
Free Cash Flow After Leases
-899.421,143-359.321,290114.443,709

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
215.94266.94291.39214.77227.63603.27
Change in Working Capital
779.07779.07-938.031,346-1,2682,711